References
- Robertson J. I. S. Drugs 1983; 25((Suppl. 2))11
- Ekelund L. G., Olsson A. G., Oro L., et al. Br. Heart J. 1976; 38: 155
- Johnsson G., Regardh C. G., Solvell L. Acta Pharmacol. Toxicol. 1975; 36((Suppl. I.V))31
- Jotdo L., Attman P. O., Aurell M., Johansson L., Johnsson G., Regardh C. G. Clin. Pharmacokinet. 1980; 5: 169
- Lennard M. S., Silas J. H., Freestone S., Trevethick J. Br. J. Clin. Pharmacol. 1982; 14: 301
- Yuen K. H., Chan K. L., Toh W. T., Peh K. K., Ang H. H., Ong B. L. Drug Dev. Ind. Pharm. 1996; 22(4)329
- Weincr D. L. Statistics in the Pharmaceutical Industry, C. R. Buncher, J. Y. Tsay. Marcel Dekker Inc., New York 1981; 205
- Gibaldi M., Perrier D. Pharmacokinetics, 2nd Ed. Marcel Dekker Inc., New York 1982; 145
- Wagner J. G. Fundamentals of Clinical Pharmacokinetics, 1st Ed. Drug Intelligence Publications, Inc., Hamilton, IL 1975; 285
- Grahnen A. Pharm. Int. 1984; 5: 100
- Westlake W. J. Biopharmaceutical Statistics for Drug Development, K. E. Peace. Marcel Dekker Inc., New York 1988; 329
- Westlake W. J. Biometrics 1976; 32: 741
- Diletti E., Hauschkc D., Steinijans V. W. Int. J. Clin. Pharmacol. Ther. Toxicol. 1991; 29: 1
- Sandberg A., Abrahamsson B., Sjogren J. Int. J. Pharm. 1991; 68: 167
- Regardh C. G., Borg K. O., Johansson R., Johnsson G., Palmer L. J. Pharmacokinet. Biopharm. 1974; 2: 347
- Clark D. W. J. Drugs 1985; 29: 342